Synergy CHC (SNYR) Competitors $3.24 0.00 (0.00%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SNYR vs. VIRI, SAVA, OCX, TCRX, CABA, ADAG, UNCY, ENTX, FBRX, and IOBTShould you be buying Synergy CHC stock or one of its competitors? The main competitors of Synergy CHC include Virios Therapeutics (VIRI), Cassava Sciences (SAVA), OncoCyte (OCX), TScan Therapeutics (TCRX), Cabaletta Bio (CABA), Adagene (ADAG), Unicycive Therapeutics (UNCY), Entera Bio (ENTX), Forte Biosciences (FBRX), and IO Biotech (IOBT). These companies are all part of the "pharmaceutical products" industry. Synergy CHC vs. Its Competitors Virios Therapeutics Cassava Sciences OncoCyte TScan Therapeutics Cabaletta Bio Adagene Unicycive Therapeutics Entera Bio Forte Biosciences IO Biotech Virios Therapeutics (NASDAQ:VIRI) and Synergy CHC (NASDAQ:SNYR) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk. Do institutionals and insiders believe in VIRI or SNYR? 9.1% of Virios Therapeutics shares are held by institutional investors. 12.2% of Virios Therapeutics shares are held by insiders. Comparatively, 56.6% of Synergy CHC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings & valuation, VIRI or SNYR? Synergy CHC has higher revenue and earnings than Virios Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVirios TherapeuticsN/AN/A-$5.30M-$0.27-17.78Synergy CHC$33.59M0.89$2.12MN/AN/A Does the media favor VIRI or SNYR? In the previous week, Synergy CHC had 1 more articles in the media than Virios Therapeutics. MarketBeat recorded 1 mentions for Synergy CHC and 0 mentions for Virios Therapeutics. Synergy CHC's average media sentiment score of 0.67 beat Virios Therapeutics' score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media. Company Overall Sentiment Virios Therapeutics Neutral Synergy CHC Positive Is VIRI or SNYR more profitable? Synergy CHC's return on equity of -8.48% beat Virios Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Virios TherapeuticsN/A -130.33% -115.00% Synergy CHC N/A -8.48%12.75% Do analysts recommend VIRI or SNYR? Virios Therapeutics currently has a consensus target price of $5.00, indicating a potential upside of 4.17%. Synergy CHC has a consensus target price of $10.00, indicating a potential upside of 208.64%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts plainly believe Synergy CHC is more favorable than Virios Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virios Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Synergy CHC 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummarySynergy CHC beats Virios Therapeutics on 11 of the 12 factors compared between the two stocks. Get Synergy CHC News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNYR vs. The Competition Export to ExcelMetricSynergy CHCCONS PD IndustryStaples SectorNASDAQ ExchangeMarket Cap$29.79M$33.81B$16.44B$9.05BDividend YieldN/A2.68%3.10%4.01%P/E RatioN/A33.1520.3320.24Price / Sales0.891.8557.00118.48Price / Cash12.1816.4914.8758.10Price / Book-1.708.896.175.67Net Income$2.12M$1.19B$685.51M$249.21M7 Day Performance33.33%4.15%2.67%3.28%1 Month Performance73.26%2.92%1.36%5.55%1 Year PerformanceN/A37.90%7.69%21.09% Synergy CHC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNYRSynergy CHC3.7665 of 5 stars$3.24flat$10.00+208.6%N/A$29.79M$33.59M0.0040VIRIVirios TherapeuticsN/A$4.76-2.9%$5.00+5.0%+1,899.2%$91.67MN/A-17.635SAVACassava Sciences3.8651 of 5 stars$1.90+0.3%$54.50+2,776.0%-81.3%$91.55MN/A-1.2630OCXOncoCyte2.0146 of 5 stars$3.18+16.3%$6.06+90.9%+3.8%$90.80M$3.84M-0.90120TCRXTScan Therapeutics1.9801 of 5 stars$1.60+10.3%$7.80+387.5%-74.2%$90.54M$2.82M-1.47100CABACabaletta Bio1.5431 of 5 stars$1.78+1.4%$14.43+712.9%-78.7%$90.06MN/A-0.7050ADAGAdagene2.0095 of 5 stars$1.91flat$8.00+319.9%-35.0%$89.75M$103.20K0.00260Gap UpUNCYUnicycive Therapeutics3.1479 of 5 stars$7.10-0.2%$60.00+745.7%-5.4%$89.74M$680K-1.399High Trading VolumeENTXEntera Bio2.6037 of 5 stars$1.97+0.3%$10.00+408.9%+18.9%$89.31M$180K-7.5620FBRXForte Biosciences2.5509 of 5 stars$13.31+4.3%$61.00+358.5%+67,596.1%$88.97MN/A-0.835Gap DownIOBTIO Biotech2.6591 of 5 stars$1.34+2.7%$9.33+599.1%+33.2%$87.95MN/A-0.9730Positive NewsGap Up Related Companies and Tools Related Companies Virios Therapeutics Competitors Cassava Sciences Competitors OncoCyte Competitors TScan Therapeutics Competitors Cabaletta Bio Competitors Adagene Competitors Unicycive Therapeutics Competitors Entera Bio Competitors Forte Biosciences Competitors IO Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNYR) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synergy CHC Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synergy CHC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
